CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Fundação Pio XII (FP). Hospital do Câncer de Barretos (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Ciências Biologicas from Universidade Federal de Viçosa (2003), master's at Agronomy from Universidade Federal de Viçosa (2005) and doctorate at Bioquímica from Faculdade de Medicina de Ribeirão Preto (2009). Has experience in Biochemistry, focusing on Molecular Biology, acting on the following subjects: dna mitocondrial, rapd-pcr, piau-vermelho, transformação and crinipellis perniciosa. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Individuals with hereditary breast cancer (HBC) have an increased cancer risk and may benefit from PARP-targeted therapy with PARP inhibitors (PARPi). Additionally, symptomatic or asymptomatic first-degree relatives have a 50% chance of being carriers of the segregating mutation in the family. Most genes associated with HBC are involved in DNA damage repair. However, about 50% of HBC case…
Cancer is responsible for a significant and growing number of patients in the world, representing the second leading cause of death worldwide. Among the advances in the development of new anti-tumor therapeutic alternatives, selective induction of cell death stands out as a fundamental tool. In particular, the tumor necrosis factor-related apoptosis-inducing ligand, TRAIL, induces selecti…
| 1 / 1 | Completed research grants |
| 1 / 1 | Completed scholarships in Brazil |
| 2 / 2 | All research grants and scholarships |
| Associated processes | |